Bradykinin prevents the apoptosis of NIT-1 cells induced by TNF-α via the PI3K/Akt and MAPK signaling pathways

International Journal of Molecular Medicine

Volumn 29, Issue 5, 2012, Pages 891-898

  Xu, Xizhen ^a   Tu, Ling ^a   Jiang, Wei ^a   Feng, Wenjing ^a   Zhao, Chun Xia ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Bradykinin; NIT 1; TNF

Indexed keywords

BRADYKININ; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BRADYKININ; CASPASE 3; CELL LINE; GENE EXPRESSION REGULATION; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863287281     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.922     Document Type: Article

References (28)

1. Marceau F and Regoli D: Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3: 845-852, 2004. (Pubitemid 39405945)
2. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F and Adam A: The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99: 6-38, 2005. (Pubitemid 41366887)
3. Kishi K, Muromoto N and Nakaya Y, et al: Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47: 550-558, 1998. (Pubitemid 28160444)
4. Campbell DJ, Kladis A and Zhang Y, et al: Increased tissue kallikrein levels in type 2 diabetes. Diabetologia 53: 779-785, 2010.
5. Kakoki M, Sullivan KA and Backus C, et al: Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci USA 107: 10190-10195, 2010.
6. Zhao C, Wang P and Xiao X, et al: Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension 42: 1026-1033, 2003. (Pubitemid 37413748)
7. Pruneau D, Belichard P, Sahel JA and Combal JP: Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 11: 507-514, 2010.
8. Wang H, Lin L and Jiang J, et al: Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther 307: 753-764, 2003. (Pubitemid 37310693)
9. Xu X, Zhao CX and Wang L, et al: Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes 59: 997-1005, 2010.
10. Yao YY, Yin H, Shen B, Chao L and Chao J: Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept 140: 12-20, 2007. (Pubitemid 46275053)
11. Chao J, Li HJ and Yao YY, et al: Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension 49: 490-497, 2007.
12. Colie S, Pecher C, Girolami JP and Blaes N: Modulation by bradykinin and nitric oxide of angiotensin II-induced apoptosis in a vascular smooth muscle cell phenotype. Int Immunopharmacol 8: 231-236, 2008.
13. Yan JT, Wang T and Wang DW: Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis. Acta Pharmacol Sin 30: 1253-1261, 2009.
14. Petraki CD, Karavana VN, Revelos KI, Luo LY and Diamandis EP: Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem J 34: 313-322, 2002. (Pubitemid 36543075)
15. Araujo RC, Mori MA and Merino VF, et al: Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem 387: 431-436, 2006.
16. Stephens LA, Thomas HE and Ming L, et al: Tumor necrosis factor-α-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic β cells. Endocrinology 140: 3219-3227, 1999. (Pubitemid 30650640)
17. Shirakawa J, Amo K and Ohminami H, et al: Protective effects of dipeptidyl peptidase-4 (DPP-4) inhibitor against increased β cell apoptosis induced by dietary sucrose and linoleic acid in mice with diabetes. J Biol Chem 286: 25467-25476, 2011.
18. McKenzie MD, Carrington EM and Kaufmann T, et al: Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells. Diabetes 57: 1284-1292, 2008.
19. Bovenzi V, Savard M, Morin J, Cuerrier CM, Grandbois M and Gobeil FJ: Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli. J Cell Physiol 222: 168-176, 2010.
20. Xia CF, Yin H, Borlongan CV, Chao L and Chao J: Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43: 452-459, 2004. (Pubitemid 38174153)
21. Manolis AJ, Marketou ME, Gavras I and Gavras H: Cardioprotective properties of bradykinin: role of the B(2) receptor. Hypertens Res 33: 772-777, 2010.
22. Kakoki M, Takahashi N, Jennette JC and Smithies O: Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci USA 101: 13302-13305, 2004. (Pubitemid 39209660)
23. Buleon M, Allard J and Jaafar A, et al: Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol 294: F1249-F1256, 2008.
24. Doggrell SA: Bradykinin B2 receptors as a target in diabetic nephropathy. Curr Opin Investig Drugs 7: 251-255, 2006.
25. Doggrell SA: Bradykinin B2 receptors - a target in diabetic nephropathy. Expert Opin Ther Targets 9: 411-414, 2005.
26. Friedrichsen BN, Neubauer N and Lee YC, et al: Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 188: 481-492, 2006.
27. Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C and Bernal-Mizrachi E: Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 9 (Suppl 2): 147-157, 2007. (Pubitemid 47543137)
28. Yin H, Chao L and Chao J: Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem 280: 8022-8030, 2005. (Pubitemid 40349700)